2,122
Views
2
CrossRef citations to date
0
Altmetric
Review Article

Emerging role of leptin in joint inflammation and destruction

ORCID Icon &
Pages 27-34 | Received 24 Apr 2021, Accepted 23 Jun 2021, Published online: 06 Aug 2021

References

  • Smolen JS, Aletaha D, Barton A, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4:18001.
  • Neumann E, Junker S, Schett G, et al. Adipokines in bone disease. Nat Rev Rheumatol. 2016;12(5):296–302.
  • Abella V, Scotece M, Conde J, et al. Leptin in the interplay of inflammation, metabolism and immune system disorders. Nat Rev Rheumatol. 2017;13(2):100–109.
  • Procaccini C, La Rocca C, Carbone F, et al. Leptin as immune mediator: interaction between neuroendocrine and immune system. Dev Comp Immunol. 2017;66:120–129.
  • Francisco V, Pino J, Campos-Cabaleiro V, et al. Obesity, fat mass and immune system: role for leptin. Front Physiol. 2018;9:640.
  • Francisco V, Pino J, Gonzalez-Gay MA, et al. Adipokines and inflammation: is it a question of weight? Br J Pharmacol. 2018;175(10):1569–1579.
  • MacDonald IJ, Liu SC, Huang CC, Kuo SJ, et al. Associations between adipokines in arthritic disease and implications for obesity. IJMS. 2019;20(6):1505.
  • Francisco V, Ruiz-Fernández C, Pino J, et al. Adipokines: linking metabolic syndrome, the immune system, and arthritic diseases. Biochem Pharmacol. 2019;165:196–206.
  • Carrión M, Frommer KW, Pérez-García S, et al. The adipokine network in rheumatic joint diseases. IJMS. 2019;20(17):4091.
  • Żelechowska P, Brzezińska-Błaszczyk E, Kusowska A, et al. The role of adipokines in the modulation of lymphoid lineage cell development and activity: an overview. Obes Rev. 2020;21(10):e13055.
  • Toussirot E. Mini-review: the contribution of adipokines to joint inflammation in inflammatory rheumatic diseases. Front Endocrinol (Lausanne). 2020;11:606560.
  • Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425–432.
  • Smith-Kirwin SM, O'Connor DM, De Johnston J, et al. Leptin expression in human mammary epithelial cells and breast milk. J Clin Endocrinol Metab. 1998;83(5):1810–1813.
  • De Rosa V, Procaccini C, Calì G, et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity. 2007;26(2):241–255.
  • Taildeman J, Pérez-Novo CA, Rottiers I, et al. Human mast cells express leptin and leptin receptors. Histochem Cell Biol. 2009;131(6):703–711.
  • Suzukawa M, Nagase H, Ogahara I, et al. Leptin enhances survival and induces migration, degranulation, and cytokine synthesis of human basophils. J Immunol. 2011;186(9):5254–5260.
  • Wolsk E, Mygind H, Grøndahl TS, et al. Human skeletal muscle releases leptin in vivo. Cytokine. 2012;60(3):667–673.
  • Zhou Y, Yu X, Chen H, et al. Leptin deficiency shifts mast cells toward anti-inflammatory actions and protects mice from obesity and diabetes by polarizing M2 macrophages. Cell Metab. 2015;22(6):1045–1058.
  • Behnes M, Brueckmann M, Lang S, et al. Alterations of leptin in the course of inflammation and severe sepsis. BMC Infect Dis. 2012;12(1):217.
  • Procaccini C, De Rosa V, Galgani M, et al. An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity. 2010;33(6):929–941.
  • Ubags ND, Vernooy JH, Burg E, et al. The role of leptin in the development of pulmonary neutrophilia in infection and acute lung injury. Crit Care Med. 2014;42(2):e143–e151.
  • Zhou Y, Rui L. Leptin signaling and leptin resistance. Front Med. 2013;7(2):207–222.
  • Tang CH, Lu DY, Yang RS, et al. Leptin-induced IL-6 production is mediated by leptin receptor, insulin receptor substrate-1, phosphatidylinositol 3-kinase, Akt, NF-kappaB, and p300 pathway in microglia. J Immunol. 2007;179(2):1292–1302.
  • Gómez R, Conde J, Scotece M, et al. What's new in our understanding of the role of adipokines in rheumatic diseases? Nat Rev Rheumatol. 2011;7(9):528–536.
  • Scotece M, Conde J, Gómez R, et al. Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases. Mediators Inflamm. 2012;2012:125458.
  • Conde J, Scotece M, Abella V, et al. An update on leptin as immunomodulator. Expert Rev Clin Immunol. 2014;10(9):1165–1170.
  • Scotece M, Conde J, Vuolteenaho K, et al. Adipokines as drug targets in joint and bone disease. Drug Discovery Today. 2014;19(3):241–258.
  • Feijóo-Bandín S, Portolés M, Roselló-Lletí E, et al. 20 years of leptin: role of leptin in cardiomyocyte physiology and physiopathology. Life Sci. 2015;140:10–18.
  • Ramos-Lobo AM, Donato J. Jr. The role of leptin in health and disease. Temperature (Austin). 2017;4(3):258–291.
  • Münzberg H, Morrison CD. Structure, production and signaling of leptin. Metabolism. 2015;64(1):13–23.
  • Frühbeck G. Intracellular signalling pathways activated by leptin. Biochem J. 2006;393(Pt 1):7–20.
  • Wada N, Hirako S, Takenoya F, et al. Leptin and its receptors. J Chem Neuroanat. 2014;61–62:191–199.
  • Conde J, Scotece M, López V, et al. Adiponectin and leptin induce VCAM-1 expression in human and murine chondrocytes. PloS One. 2012;7(12):e52533.
  • Procaccini C, Jirillo E, Matarese G. Leptin as an immunomodulator. Mol Aspects Med. 2012;33(1):35–45.
  • Wrann CD, Laue T, Hübner L, et al. Short-term and long-term leptin exposure differentially affect human natural killer cell immune functions. Am J Physiol Endocrinol Metab. 2012;302(1):E108–16.
  • Nave H, Mueller G, Siegmund B, et al. Resistance of Janus kinase-2 dependent leptin signaling in natural killer (NK) cells: a novel mechanism of NK cell dysfunction in diet-induced obesity. Endocrinology. 2008;149(7):3370–3378.
  • Lo CK, Lam QL, Yang M, et al. Leptin signaling protects NK cells from apoptosis during development in mouse bone marrow. Cell Mol Immunol. 2009;6(5):353–360.
  • Shirshev SV, Nekrasova IV, Orlova EG, et al. Roles of leptin and ghrelin in the regulation of the phenotype and cytokine production by NK cells from peripheral blood. Dokl Biol Sci. 2016;470(1):249–252.
  • Zhao Y, Sun R, You L, et al. Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. Biochem Biophys Res Commun. 2003;300(2):247–252.
  • Lamas B, Goncalves-Mendes N, Nachat-Kappes R, et al. Leptin modulates dose-dependently the metabolic and cytolytic activities of NK-92 cells. J Cell Physiol. 2013;228(6):1202–1209.
  • Oswald J, Büttner M, Jasinski-Bergner S, et al. Leptin affects filopodia and cofilin in NK-92 cells in a dose- and time-dependent manner. Eur J Histochem. 2018;62(1):2848.
  • Santos-Alvarez J, Goberna R, Sánchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol. 1999;194(1):6–11.
  • Iikuni N, Lam QL, Lu L, et al. Leptin and inflammation. Curr Immunol Rev. 2008;4(2):70–79.
  • Amarilyo G, Iikuni N, Liu A, et al. Leptin enhances availability of apoptotic cell-derived self-antigen in systemic lupus erythematosus. PloS One. 2014;9(11):e112826.
  • Dayakar A, Chandrasekaran S, Veronica J, et al. Leptin induces the phagocytosis and protective immune response in Leishmania donovani infected THP-1 cell line and human PBMCs. Exp Parasitol. 2016;160:54–59.
  • Gruen ML, Hao M, Piston DW, et al. Leptin requires canonical migratory signaling pathways for induction of monocyte and macrophage chemotaxis. Am J Physiol Cell Physiol. 2007;293(5):C1481–C1488.
  • Lam QL, Liu S, Cao X, et al. Involvement of leptin signaling in the survival and maturation of bone marrow-derived dendritic cells. Eur J Immunol. 2006;36(12):3118–3130.
  • Mattioli B, Giordani L, Quaranta MG, et al. Leptin exerts an anti-apoptotic effect on human dendritic cells via the PI3K-Akt signaling pathway. FEBS Lett. 2009;583(7):1102–1106.
  • Mattioli B, Straface E, Quaranta MG, et al. Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming. J Immunol. 2005;174(11):6820–6828.
  • Mattioli B, Straface E, Matarrese P, et al. Leptin as an immunological adjuvant: enhanced migratory and CD8+ T cell stimulatory capacity of human dendritic cells exposed to leptin. Faseb J. 2008;22(6):2012–2022.
  • Moraes-Vieira PM, Larocca RA, Bassi EJ, Peron JP, et al. Leptin deficiency impairs maturation of dendritic cells and enhances induction of regulatory T and Th17 cells. Eur J Immunol. 2014;44(3):794–806.
  • Bruno A, Conus S, Schmid I, et al. Apoptotic pathways are inhibited by leptin receptor activation in neutrophils. J Immunol. 2005;174(12):8090–8096.
  • Montecucco F, Bianchi G, Gnerre P, et al. Induction of neutrophil chemotaxis by leptin: crucial role for p38 and Src kinases. Ann N Y Acad Sci. 2006;1069:463–471.
  • Brotfain E, Hadad N, Shapira Y, et al. Neutrophil functions in morbidly obese subjects. Clin Exp Immunol. 2015;181(1):156–163.
  • Wong CK, Cheung PF, Lam CW. Leptin-mediated cytokine release and migration of eosinophils: implications for immunopathophysiology of allergic inflammation. Eur J Immunol. 2007;37(8):2337–2348.
  • Grotta MB, Squebola-Cola DM, Toro AA, et al. Obesity increases eosinophil activity in asthmatic children and adolescents. BMC Pulm Med. 2013;13:39.
  • Lord GM, Matarese G, Howard JK, et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature. 1998;394(6696):897–901.
  • Howard JK, Lord GM, Matarese G, et al. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest. 1999;104(8):1051–1059.
  • Kim SY, Lim JH, Choi SW, et al. Preferential effects of leptin on CD4 T cells in central and peripheral immune system are critically linked to the expression of leptin receptor. Biochem Biophys Res Commun. 2010;394(3):562–568.
  • Lamas A, Lopez E, Carrio R, et al. Adipocyte and leptin accumulation in tumor-induced thymic involution. Int J Mol Med. 2016;37(1):133–138.
  • Zeng H, Chi H. The interplay between regulatory T cells and metabolism in immune regulation. Oncoimmunology. 2013;2(11):e26586.
  • Lourenço EV, Liu A, Matarese G, et al. Leptin promotes systemic lupus erythematosus by increasing autoantibody production and inhibiting immune regulation. Proc Natl Acad Sci U S A. 2016;113(38):10637–10642.
  • Orlova EG, Shirshev SV. Role of PKA and PI3K in leptin and ghrelin regulation of adaptive subpopulations of regulatory CD4+ T-lymphocyte formation. Biochemistry (Mosc). 2017;82(9):1061–1072.
  • Lord GM, Matarese G, Howard JK, et al. Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leukocyte Biol. 2002;72(2):330–338.
  • Wei R, Hu Y, Dong F, et al. Hepatoma cell-derived leptin downregulates the immunosuppressive function of regulatory T-cells to enhance the anti-tumor activity of CD8+ T-cells. Immunol Cell Biol. 2016;94(4):388–399.
  • Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002;110(8):1093–1103.
  • Wagner NM, Brandhorst G, Czepluch F, et al. Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk. Obesity (Silver Spring, MD). 2013;21(3):461–468.
  • Martín-Romero C, Santos-Alvarez J, Goberna R, et al. Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol. 2000;199(1):15–24.
  • Oral EA, Javor ED, Ding L, et al. Leptin replacement therapy modulates circulating lymphocyte subsets and cytokine responsiveness in severe lipodystrophy. J Clin Endocrinol Metab. 2006;91(2):621–628.
  • Saucillo DC, Gerriets VA, Sheng J, et al. Leptin metabolically licenses T cells for activation to link nutrition and immunity. J Immunol. 2014;192(1):136–144.
  • Scotece M, Pérez T, Conde J, et al. Adipokines induce pro-inflammatory factors in activated Cd4+ T cells from osteoarthritis patient. J Orthop Res. 2017;35(6):1299–1303.
  • Batra A, Okur B, Glauben R, et al. Leptin: a critical regulator of CD4+ T-cell polarization in vitro and in vivo. Endocrinology. 2010;151(1):56–62.
  • Yu Y, Liu Y, Shi FD, et al. Cutting edge: leptin-induced RORγt expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosus. J Immunol. 2013;190(7):3054–3058.
  • Wang S, Baidoo SE, Liu Y, et al. T cell-derived leptin contributes to increased frequency of T helper type 17 cells in female patients with Hashimoto's thyroiditis. Clin Exp Immunol. 2013;171(1):63–68.
  • Reis BS, Lee K, Fanok MH, et al. Leptin receptor signaling in T cells is required for Th17 differentiation. J Immunol. 2015;194(11):5253–5260.
  • Gerriets VA, Danzaki K, Kishton RJ, et al. Leptin directly promotes T-cell glycolytic metabolism to drive effector T-cell differentiation in a mouse model of autoimmunity. Eur J Immunol. 2016;46(8):1970–1983.
  • Lam QL, Wang S, Ko OK, et al. Leptin signaling maintains B-cell homeostasis via induction of Bcl-2 and Cyclin D1. Proc Natl Acad Sci USA. 2010;107(31):13812–13817.
  • Agrawal S, Gollapudi S, Su H, et al. Leptin activates human B cells to secrete TNF-α, IL-6, and IL-10 via JAK2/STAT3 and p38MAPK/ERK1/2 signaling pathway. J Clin Immunol. 2011;31(3):472–478.
  • Gupta S, Agrawal S, Gollapudi S. Increased activation and cytokine secretion in B cells stimulated with leptin in aged humans. Immun Ageing. 2013;10(1):3.
  • Xu T, Xie W, Ma Y, et al. Leptin/OB-R pathway promotes IL-4 secretion from B lymphocytes and induces salivary gland epithelial cell apoptosis in Sjögren's syndrome. Oncotarget. 2017;8(38):63417–63429.
  • Frasca D, Diaz A, Romero M, et al. Leptin induces immunosenescence in human B cells. Cell Immunol. 2020;348:103994.
  • Bennett BD, Solar GP, Yuan JQ, et al. A role for leptin and its cognate receptor in hematopoiesis. Curr Biol. 1996;6(9):1170–1180.
  • Claycombe K, King LE, Fraker PJ. A role for leptin in sustaining lymphopoiesis and myelopoiesis. Proc Natl Acad Sci USA. 2008;105(6):2017–2021.
  • Tanaka M, Suganami T, Kim-Saijo M, et al. Role of central leptin signaling in the starvation-induced alteration of B-cell development. J Neurosci. 2011;31(23):8373–8380.
  • Anders HJ, Rihl M, Heufelder A, et al. Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis. Metabolism. 1999;48(6):745–748.
  • Bokarewa M, Bokarew D, Hultgren O, et al. Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis. 2003;62(10):952–956.
  • Härle P, Pongratz G, Weidler C, et al. Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis. 2004;63(7):809–816.
  • Toussirot E, Nguyen NU, Dumoulin G, et al. Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis. Rheumatology (Oxford). 2005;44(1):120–125.
  • Popa C, Netea MG, Radstake TR, et al. Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis. 2005;64(8):1195–1198.
  • Otero M, Lago R, Gomez R, et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis. 2006;65(9):1198–1201.
  • Olama SM, Senna MK, Elarman M. Synovial/serum leptin ratio in rheumatoid arthritis: the association with activity and erosion. Rheumatol Int. 2012;32(3):683–690.
  • Toussirot E, Grandclément E, Gaugler B, et al. Serum adipokines and adipose tissue distribution in rheumatoid arthritis and ankylosing spondylitis. A comparative study. Front Immunol. 2013;4:453.
  • Tian G, Liang JN, Pan HF, et al. Increased leptin levels in patients with rheumatoid arthritis: a meta-analysis. Ir J Med Sci. 2014;183(4):659–666.
  • Lee SW, Park MC, Park YB, et al. Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis. Rheumatol Int. 2007;27(6):537–540.
  • Yoshino T, Kusunoki N, Tanaka N, et al. Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis. Intern Med. 2011;50(4):269–275.
  • Lee YH, Bae SC. Circulating leptin level in rheumatoid arthritis and its correlation with disease activity: a meta-analysis. Z Rheumatol. 2016;75(10):1021–1027.
  • Cao H, Lin J, Chen W, et al. Baseline adiponectin and leptin levels in predicting an increased risk of disease activity in rheumatoid arthritis: a meta-analysis and systematic review. Autoimmunity. 2016;49(8):547–553.
  • Toussirot E, Streit G, Wendling D. The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr Med Chem. 2007;14(10):1095–1100.
  • Schäffler A, Ehling A, Neumann E, et al. Adipocytokines in synovial fluid. JAMA. 2003;290(13):1709–1710.
  • Targońska-Stepniak B, Dryglewska M, Majdan M. Adiponectin and leptin serum concentrations in patients with rheumatoid arthritis. Rheumatol Int. 2010;30(6):731–737.
  • Rho YH, Solus J, Sokka T, et al. Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum. 2009;60(7):1906–1914.
  • Giles JT, Allison M, Bingham CO, 3rd, et al. Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis. Arthritis Rheum. 2009;61(9):1248–1256.
  • Giles JT, van der Heijde DM, Bathon JM. Association of circulating adiponectin levels with progression of radiographic joint destruction in rheumatoid arthritis. Ann Rheum Dis. 2011;70(9):1562–1568.
  • Klein-Wieringa IR, van der Linden MP, Knevel R, et al. Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis. Arthritis Rheum. 2011;63(9):2567–2574.
  • Meyer M, Sellam J, Fellahi S, et al. Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort. Arthritis Res Ther. 2013;15(6):R210.
  • Neumann E, Frommer KW, Vasile M, et al. Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases? Arthritis Rheum. 2011;63(5):1159–1169.
  • Francisco V, Pérez T, Pino J, et al. Biomechanics, obesity, and osteoarthritis. the role of adipokines: when the levee breaks. J Orthop Res. 2018;36(2):594–604.
  • Schroeter MR, Leifheit M, Sudholt P, et al. Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion. Circ Res. 2008;103(5):536–544.
  • Manuel-Apolinar L, López-Romero R, Zarate A, et al. Leptin mediated ObRb receptor increases expression of adhesion intercellular molecules and cyclooxygenase 2 on murine aorta tissue inducing endothelial dysfunction. Int J Clin Exp Med. 2013;6(3):192–196.
  • Gómez R, Scotece M, Conde J, et al. Adiponectin and leptin increase IL-8 production in human chondrocytes. Ann Rheum Dis. 2011;70(11):2052–2054.
  • Conde J, Gomez R, Bianco G, et al. Expanding the adipokine network in cartilage: identification and regulation of novel factors in human and murine chondrocytes. Ann Rheum Dis. 2011;70(3):551–559.
  • Liu B, Gao YH, Dong N, et al. Differential expression of adipokines in the synovium and infrapatellar fat pad of osteoarthritis patients with and without metabolic syndrome. Connect Tissue Res. 2019;60(6):611–618.
  • Simopoulou T, Malizos KN, Iliopoulos D, et al. Differential expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Osteoarthr Cartil. 2007;15(8):872–883.
  • Ku JH, Lee CK, Joo BS, et al. Correlation of synovial fluid leptin concentrations with the severity of osteoarthritis. Clin Rheumatol. 2009;28(12):1431–1435.
  • Yang WH, Liu SC, Tsai CH, et al. Leptin induces IL-6 expression through OBRl receptor signaling pathway in human synovial fibroblasts. PloS One. 2013;8(9):e75551.
  • Muraoka S, Kusunoki N, Takahashi H, et al. Leptin stimulates interleukin-6 production via janus kinase 2/signal transducer and activator of transcription 3 in rheumatoid synovial fibroblasts. Clin Exp Rheumatol. 2013;31(4):589–595.
  • Busso N, So A, Chobaz-Péclat V, et al. Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol. 2002;168(2):875–882.
  • Deng J, Liu Y, Yang M, et al. Leptin exacerbates collagen-induced arthritis via enhancement of Th17 cell response. Arthritis Rheum. 2012;64(11):3564–3573.
  • Xibillé-Friedmann D, Bustos-Bahena C, Hernández-Góngora S, et al. Two-year follow-up of plasma leptin and other cytokines in patients with rheumatoid arthritis. Ann Rheum Dis. 2010;69(5):930–931.
  • Karvounaris SA, Sidiropoulos PI, Papadakis JA, et al. Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study. Ann Rheum Dis. 2007;66(1):28–33.
  • Crowson CS, Myasoedova E, Davis JM, 3rd, et al. Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. J Rheumatol. 2011;38(1):29–35.
  • Ferraz-Amaro I, González-Juanatey C, López-Mejias R, et al. Metabolic syndrome in rheumatoid arthritis. Mediators Inflamm. 2013;2013:710928.